Onyx Biotec Ltd

NSE: ONYX · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹37.75
Market cap: ₹68.45 Cr
Revenue (annual): ₹69.47 Cr
Net profit (annual): ₹-0.21 Cr
P/E (TTM): -319.3×Sector 47.4×
Promoter holding: 65.10%
FII holding: 1.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Selling 3 Other Announcement 3 Management Change 2 Fund Raise 2 Financial Results 2 Price Movement Clarification 1 Open Offer 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 May 2026 17:41 IST NSE

Financial Results

Onyx Biotec H2 FY26 Results: Net Profit ₹0.7 Cr, Down 65.0% YoY

Onyx Biotec Ltd reported revenue from operations of ₹34.9 Cr (+9.7% YoY) and net profit of ₹0.7 Cr (-65.0% YoY) for H2 FY26.

Key figure: Net profit ₹0.7 Cr · -65.0% YoY

Open full results → Read the filing ↗

14 May 2026 17:40 IST NSE

Financial Results

Onyx Biotec Financial Results

Onyx Biotec Limited approved audited financial results for the year ended March 31, 2026. The company reported utilization of ₹25.38 Crore from its recent IPO proceeds.

Value: ₹25.38 Cr

Read the filing ↗